Positive News Sentiment NASDAQ:NSTG NanoString Technologies - NSTG Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoString Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $9.31 +0.20 (+2.20%) (As of 03/30/2023 12:00 AM ET) Add Compare Share Share Today's Range$8.99▼$9.3650-Day Range$7.98▼$12.5752-Week Range$4.37▼$37.06Volume357,006 shsAverage Volume667,192 shsMarket Capitalization$435.61 millionP/E RatioN/ADividend YieldN/APrice Target$20.57 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability NanoString Technologies MarketRank™ ForecastAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside121.0% Upside$20.57 Price TargetShort InterestBearish7.67% of Shares Sold ShortDividend StrengthN/ASustainability-1.07Upright™ Environmental ScoreNews SentimentN/AInsider TradingAcquiring Shares$223,200 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($2.45) to ($1.56) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.11 out of 5 starsMedical Sector490th out of 1,009 stocksBiological Products, Except Diagnostic Industry85th out of 166 stocks 3.4 Analyst's Opinion Consensus RatingNanoString Technologies has received a consensus rating of Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $20.57, NanoString Technologies has a forecasted upside of 121.0% from its current price of $9.31.Amount of Analyst CoverageNanoString Technologies has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.67% of the outstanding shares of NanoString Technologies have been sold short.Short Interest Ratio / Days to CoverNanoString Technologies has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in NanoString Technologies has recently increased by 17.32%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldNanoString Technologies does not currently pay a dividend.Dividend GrowthNanoString Technologies does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreNanoString Technologies has received a 60.58% net impact score from Upright. The largest positive contribution comes from its "Creating knowledge" impact, which is mostly driven by its "Cell analysis software", "Cell analysis systems", and "Biochemical assay kits" products. See details.Environmental SustainabilityThe Environmental Impact score for NanoString Technologies is -1.07. Previous Next 2.7 News and Social Media Coverage News SentimentNanoString Technologies has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for NanoString Technologies this week, compared to 1 article on an average week.MarketBeat FollowsOnly 2 people have added NanoString Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NanoString Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $223,200.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.50% of the stock of NanoString Technologies is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for NanoString Technologies are expected to grow in the coming year, from ($2.45) to ($1.56) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NanoString Technologies is -2.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NanoString Technologies is -2.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNanoString Technologies has a P/B Ratio of 9.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About NanoString Technologies (NASDAQ:NSTG) StockNanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. It offers the GeoMx Digital Spatial Profiler, nCounter Analysis System product platforms, GeoMx Assays, nCounter Panels & Assays and CosMx Spatial Molecular. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June, 2003 and is headquartered in Seattle, WA.Read More Receive NSTG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoString Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address NSTG Stock News HeadlinesMarch 15, 2023 | reuters.comNSTG.OQ - | Stock Price & Latest News | ReutersMarch 8, 2023 | finance.yahoo.comNanoString Reports Inducement Grants Under Nasdaq Listing RulesMarch 31, 2023 | Weiss Ratings (Ad)Urgent WarningThis was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …March 2, 2023 | finance.yahoo.comNanoString Technologies Full Year 2022 Earnings: EPS Misses ExpectationsMarch 1, 2023 | finance.yahoo.comNanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care ConferenceMarch 1, 2023 | finance.yahoo.comQ4 2022 NanoString Technologies Inc Earnings CallFebruary 23, 2023 | finance.yahoo.comNanoString to Webcast Presentation from the 43rd Annual Cowen Health Care ConferenceFebruary 14, 2023 | finance.yahoo.comNanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023March 31, 2023 | WealthPop (Ad)Adam Mesh: “This Strategy Saved My Trading Career”Adam Mesh was $50,000 in the hole - and ready to quit trading for good… Until he discovered the secret to unlocking double-digit income. This strategy has averaged 64% average gains in the last three years. Adam is hosting a free session to show ordinary folks how to execute this incredible strategy. Click here to let Adam show you how it’s done. February 6, 2023 | finance.yahoo.comNanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)February 2, 2023 | markets.businessinsider.comExpert Ratings for NanoString TechnologiesFebruary 2, 2023 | finance.yahoo.comWeill Cornell Medicine and NanoString Collaborate to Create Comprehensive Spatial Atlas of Human AnatomyJanuary 19, 2023 | finance.yahoo.comNanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular ImagerJanuary 18, 2023 | msn.comNIH outlays fall, US govt healthcare grants grow but Biopharma financings decline Y/YJanuary 8, 2023 | finance.yahoo.comNanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022January 3, 2023 | benzinga.comNational Geographic Highlights Use of the CosMx Spatial Molecular Imager in Alzheimer's Disease ResearchJanuary 3, 2023 | finance.yahoo.comNational Geographic Highlights Use of the CosMx Spatial Molecular Imager in Alzheimer’s Disease ResearchDecember 22, 2022 | finance.yahoo.comNanoString to Present at the 41st Annual J.P. Morgan Healthcare ConferenceDecember 16, 2022 | forbes.comNanostring TechnologiesDecember 16, 2022 | finance.yahoo.comThe CEO, President & Director of NanoString Technologies, Inc. (NASDAQ:NSTG), R. Gray, Just Bought 33% More SharesDecember 13, 2022 | finance.yahoo.comNanoString’s CosMx Spatial Molecular Imager Recognized by The Scientist Magazine as a Top 10 Innovation of 2022December 13, 2022 | tmcnet.comNanoString's CosMx Spatial Molecular Imager Recognized by The Scientist Magazine as a Top 10 Innovation of 2022December 6, 2022 | finance.yahoo.comNanoString Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics PlatformDecember 1, 2022 | msn.comNanoString Technologies's Return On Capital Employed InsightsNovember 10, 2022 | 247wallst.comHealth Care Fund Pura Vida Investments Increases Position in NanoString (NSTG)November 8, 2022 | seekingalpha.comNanoString slumps 19% as Q3 revenue falls, cuts FY22 revenue outlookNovember 8, 2022 | msn.comAnalyzing NanoString Technologies's Short InterestSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive NSTG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoString Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address NSTG Company Calendar Last Earnings11/09/2021Today3/31/2023Next Earnings (Estimated)5/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NSTG CUSIPN/A CIK1401708 Webwww.nanostring.com Phone(888) 358-6266Fax206-378-6288Employees766Year FoundedN/APrice Target and Rating Average Stock Price Forecast$20.57 High Stock Price Forecast$37.00 Low Stock Price Forecast$14.00 Forecasted Upside/Downside+121.0%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($3.45) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-159,540,000.00 Net Margins-125.37% Pretax Margin-125.12% Return on Equity-165.02% Return on Assets-40.01% Debt Debt-to-Equity Ratio4.95 Current Ratio4.87 Quick Ratio4.14 Sales & Book Value Annual Sales$127.26 million Price / Sales3.42 Cash FlowN/A Price / Cash FlowN/A Book Value$0.98 per share Price / Book9.50Miscellaneous Outstanding Shares46,790,000Free Float45,621,000Market Cap$435.61 million OptionableOptionable Beta1.59 Key ExecutivesRobert Bradley GrayPresident, Chief Executive Officer & DirectorMark A. WinhamSenior Vice President-OperationsKenneth Thomas BaileyChief Financial OfficerJoseph M. BeechemChief Scientific Officer, SVP-R&DDavid W. GhesquiereSenior VP-Corporate & Business DevelopmentKey CompetitorsCullinan OncologyNASDAQ:CGEMCompass TherapeuticsNASDAQ:CMPXScholar RockNASDAQ:SRRKMesoblastNASDAQ:MESOAmbrx BiopharmaNYSE:AMAMView All CompetitorsInsiders & InstitutionsCharles P Waite JrBought 12,000 shares on 3/13/2023Total: $100,200.00 ($8.35/share)Gregory NordenBought 12,500 shares on 3/7/2023Total: $123,000.00 ($9.84/share)NatixisBought 4,916 shares on 2/24/2023Ownership: 0.011%Alliancebernstein L.P.Bought 16,100 shares on 2/16/2023Ownership: 0.153%Point72 Middle East FZEBought 3,670 shares on 2/16/2023Ownership: 0.008%View All Insider TransactionsView All Institutional Transactions NSTG Stock - Frequently Asked Questions Should I buy or sell NanoString Technologies stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NSTG shares. View NSTG analyst ratings or view top-rated stocks. What is NanoString Technologies' stock price forecast for 2023? 6 Wall Street analysts have issued 1 year price objectives for NanoString Technologies' shares. Their NSTG share price forecasts range from $14.00 to $37.00. On average, they predict the company's stock price to reach $20.57 in the next year. This suggests a possible upside of 121.0% from the stock's current price. View analysts price targets for NSTG or view top-rated stocks among Wall Street analysts. How have NSTG shares performed in 2023? NanoString Technologies' stock was trading at $7.97 at the start of the year. Since then, NSTG stock has increased by 16.8% and is now trading at $9.31. View the best growth stocks for 2023 here. When is NanoString Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. View our NSTG earnings forecast. How were NanoString Technologies' earnings last quarter? NanoString Technologies, Inc. (NASDAQ:NSTG) posted its earnings results on Tuesday, November, 9th. The biotechnology company reported ($0.69) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by $0.16. The biotechnology company had revenue of $37.15 million for the quarter, compared to analyst estimates of $37.35 million. NanoString Technologies had a negative net margin of 125.37% and a negative trailing twelve-month return on equity of 165.02%. During the same period in the previous year, the company posted ($0.56) EPS. What ETFs hold NanoString Technologies' stock? ETFs with the largest weight of NanoString Technologies (NASDAQ:NSTG) stock in their portfolio include ROBO Global Healthcare Technology and Innovation ETF (HTEC), Global X Genomics & Biotechnology ETF (GNOM), Invesco Nasdaq Future Gen 200 ETF (QQQS), WisdomTree BioRevolution Fund (WDNA), Principal Healthcare Innovators ETF (BTEC), Invesco Nasdaq Biotechnology ETF (IBBQ), iShares Biotechnology ETF (IBB) and iShares U.S. Medical Devices ETF (IHI). What guidance has NanoString Technologies issued on next quarter's earnings? NanoString Technologies issued an update on its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $170.00 million-$180.00 million, compared to the consensus revenue estimate of $174.31 million. What is Brad Gray's approval rating as NanoString Technologies' CEO? 36 employees have rated NanoString Technologies Chief Executive Officer Brad Gray on Glassdoor.com. Brad Gray has an approval rating of 65% among the company's employees. What other stocks do shareholders of NanoString Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling (PD), AutoZone (AZO), Designer Brands (DBI), Bank of the Ozarks (OZRK) and Vista Outdoor (VSTO). What is NanoString Technologies' stock symbol? NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG." Who are NanoString Technologies' major shareholders? NanoString Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Avidity Partners Management LP (4.41%), Platinum Investment Management Ltd. (2.70%), Bank of America Corp DE (2.09%), Geode Capital Management LLC (1.75%), Assenagon Asset Management S.A. (1.55%) and Fisher Asset Management LLC (1.42%). Insiders that own company stock include Charles P Waite Jr, Elisha W Finney, Gregory Norden, J Chad Brown, Joseph M Beechem, K Thomas Bailey, Kirk Malloy, R Bradley Gray and Robert Hershberg. View institutional ownership trends. How do I buy shares of NanoString Technologies? Shares of NSTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is NanoString Technologies' stock price today? One share of NSTG stock can currently be purchased for approximately $9.31. How much money does NanoString Technologies make? NanoString Technologies (NASDAQ:NSTG) has a market capitalization of $435.61 million and generates $127.26 million in revenue each year. The biotechnology company earns $-159,540,000.00 in net income (profit) each year or ($3.45) on an earnings per share basis. How many employees does NanoString Technologies have? The company employs 766 workers across the globe. How can I contact NanoString Technologies? NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The official website for the company is www.nanostring.com. The biotechnology company can be reached via phone at (888) 358-6266, via email at dfarrell@nanostring.com, or via fax at 206-378-6288. This page (NASDAQ:NSTG) was last updated on 3/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.